Contracts › 75F40121C00109
75F40121C00109: Strengthening Pharmacovigilance Systems and Adverse Events Reporting for Maternal Immunization Safety in the Democratic Republic of Congo - Baa Globwp 60
Awarded to University of California, Los Angeles by Food and Drug Administration (FDA).
$2.8Mobligated
$2.8Mpotential value
30 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40121C00109 |
|---|---|
| Awardee | University of California, Los Angeles |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 27 August 2021 to 30 September 2026 |
| Potential end | 30 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 18 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record